Guideline updated for initial management of advanced prostate cancer
by Elana GotkineFor patients with noncastrate advanced prostate cancer, docetaxel, abiraterone, enzalutamide, apalutamide, or darolutamide are each recommended as standards of care with androgen depri
Updated on: January 08,2024
10
Guideline updated for initial management of advanced prostate cancer
by Elana GotkineFor patients with noncastrate advanced prostate cancer, docetaxel, abiraterone, enzalutamide, apalutamide, or darolutamide are each recommended as standards of care with androgen depri
Updated on:January 08,2024
10
